• Disclosing Orders Prohibited

      • To
      • Members, Member Firms and Market Users
      • From
      • Market Regulation Department
      • #
      • CME Group RA1615-5
      • Notice Date
      • 12 December 2016
      • Effective Date
      • 03 January 2017

    • This Advisory Notice supersedes CME Group Market Regulation Advisory Notice RA1302-5 from February 28, 2013. It is being issued to reflect revisions to NYMEX and COMEX Rule 532 (“Disclosing Orders Prohibited”) that will become effective on January 3, 2017, in connection with the December 30, 2016, termination of open outcry trading in NYMEX and COMEX products and the closure of the NYMEX and COMEX trading floor. CME and CBOT Rule 532 have not been revised.

      Click HERE to view full advisory. 

CME Group is the world’s leading derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). 
Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.

© 2026 CME Group Inc. All rights reserved.